OBJECTIVES: Our goal was to evaluate the operative outcomes of the frozen elephant trunk technique using the E-Vita Open Plus V R hybrid prosthesis in chronic aortic arch diseases and report clinical and radiological outcomes at the 1-year follow-up.
Elective frozen elephant trunk procedure using the E-Vita Open Plus prosthesis in 94 patients: a multicentre French registry 
INTRODUCTION
Surgical management of extensive arch pathological conditions involving the ascending aorta, the aortic arch and the descending aorta remains challenging and complex. Particular consideration is needed to reduce complications to the brain and spinal cord and distal organ function. The frozen elephant trunk (FET) technique was introduced and developed [1, 2] during the last 2 decades by combining surgical arch replacement and stent grafting of the proximal thoracic descending aorta in a 1-stage procedure. The E-Vita Open V R (Jotec GmBH, Hechingen, Germany) was the first off-the-shelf hybrid prosthesis in Europe and the USA intended for such a technique [3] . Considerable clinical and technical data were gathered and analysed [4, 5] . In contrast, more limited experience has been reported regarding its upgraded version, the E-Vita Open Plus V R hybrid prosthesis.
Although operative mortality and morbidity remain the primary focus, the FET technique is intended to reduce the rate of reintervention on the downstream aorta and promote favourable aortic remodelling [6, 7] . Due to the variety of aortic arch pathological conditions, whether in their presentation (chronic/acute) or by their very nature (e.g. dissection or aneurysm), such outcomes must be investigated individually [8] .
This study presents the results of a prospective multicentre study of the E-Vita Open Plus hybrid prosthesis used exclusively in patients with chronic aortic disease (CAD) using data from the French registry, which includes 17 institutions.
The purpose of this study was to evaluate (i) the operative outcomes and early results of aortic arch surgical procedures using the E-Vita Open Plus V R hybrid prosthesis to treat chronic aortic arch pathological conditions and (ii) the clinical and radiological outcomes at the 1-year follow-up examination.
MATERIALS AND METHODS

Description of the device
Designed by Heinz Jakob [3] , both the E-vita Open V R and E-vita Open Plus V R devices are similar in design. The upgraded version precludes the need for impregnation or preclotting due to the blood-tight woven polyester fabric.
The stented portion is formed of a flexible, Z-shaped nitinol wire covered by a polyester fabric and is incorporated into a proximal non-stented woven graft. Both portions have identical diameters, ranging from 20 mm to 40 mm. The stent graft is 130-160 mm long; the proximal graft is 50-70 mm long. More recently, a suture collar between the 2 portions was implemented to facilitate a tension-free, flexible anastomosis; radiopaque markers are integrated within the graft to facilitate radiological imaging.
Patients
Between February 2009 and October 2015, 94 patients with extensive thoracic aortic disease involving the aortic arch and/or descending aorta underwent elective FET procedures in 17 French centres (Annex 1 -Supplementary Material). Eighty-seven patients were included as part of the French National Registry Nouvelle Open des E-vita; 7 additional patients were included in our study.
The Nouvelle Open des E-vita is a French prospective multicentre registry initiated in 2009 to establish the reimbursement policy for the E-Vita Open Plus V R device in France. Data collection was performed prospectively through an electronic database. All included patients presented chronic aortic conditions, and there were no instances in the present series of the FET procedure for acute aortic dissection or other acute aortic diseases.
Surgical technique
No standard surgical protocol for stent graft placement and arch replacement was enforced in this multicentre study. The aortic arch was accessed by a median sternotomy in all instances. Arterial cannulation for cardiopulmonary bypass was achieved through the right subclavian artery through an interpositional graft in 60 patients (63.8%), through direct ascending aortic cannulation in 19 patients (20.2%), through femoral cannulation in 13 patients (13.8%) and through other points of access in 2 patients (2.1%).
The decision about the use of a guide wire for positioning the stent graft, the oversizing of the prosthesis and the operative strategy for arch replacement was based on the surgeon's preferences. Similarly, other adjuncts to hypothermia for neurological protection varied according to the participating centres. Antegrade selective cerebral perfusion was used in all patients, except 2 (2%) patients. All the procedures were performed under deep (33%) or moderate (77%) hypothermic circulatory arrest, as defined by the current consensus (deep between 14 C and 20 C, moderate between 21 C and 28 C) [9] . Cerebrospinal fluid (CSF) drainage was used in 4 patients (4%). Myocardial protection strategies also varied according to the individual centre, which used Custodiol, crystalloid multidose or cold blood cardioplegia.
In 26 patients (27.7%), the supra-aortic vessels were reimplanted separately with the use of additional prosthetic branches, whereas these vessels were reimplanted with the en bloc technique in the remaining 68 patients (72.3%). Preliminary left subclavian-to-left carotid bypasses had been performed in 15 patients (16%).
Operative mortality was defined as death occurring within 30 days of the index operation or later if during the same hospitalization. Late mortality was any death occurring afterwards. Similarly, morbidity was noted as either operative (if occurring within 30 days from the operation or during the same hospitalization) or late (in the remaining cases).
Aortic imaging and follow-up
All patients were entered in a prospective follow-up programme. Although compliance with a clinical follow-up was complete, complete imaging follow-up was only available for 68 patients. Follow-up visits occurred at the 3rd and 12th postoperative months and included a contrast-enhanced computed tomography scan. The status of the false lumen (FL) and downstream aorta was assessed both preoperatively and at the follow-up examination at 3 given aortic levels, as suggested by Shrestha et al. [7] : Segment A, stented part of the aorta; Segment B, downstream segment up to the celiac trunk; and Segment C, below the celiac trunk. The FL was categorized as reported earlier [10] : patent (homogeneously contrast enhanced), partially thrombosed (presence of thrombus in any part of it with preserved flow) or completely thrombosed (complete lack of blood flow). Within each segment, the maximum total aortic diameter was identified. Subsequently, the maximal diameters of the true lumen and the FL were measured using Endosize V R software [11] (Therenva, Rennes, France).
Data collection and statistical analysis
Informed consent to enter the study was obtained from all patients. As part of the Nouvelle Open des E-vita. Registry, the pre-, intra-and postoperative data were prospectively collected within an electronic database. Data collection and management were performed according to the current guidelines [8] . Continuous and categorical data were presented as mean ± standard deviation and as percentages, respectively. Intergroup comparison was performed using the v 2 test for categorical variables and analysis of variance for continuous variables. The limited number of observations and of adverse events precluded a formal risk factor assessment through multivariate analysis.
RESULTS
Patient characteristics
The main indications for surgical procedures were chronic aortic dissection (50%), including post-dissection aneurysm after type A aortic dissection repair (34%) and chronic post-dissection aneurysm after chronic type B aortic dissection (16%) and degenerative thoracic aortic aneurysm (39.4%); miscellaneous aetiologies were observed in the remainder (10.6%).
The mean age of the patient population was 64 ± 11.6 years. Previous cardiac or aortic operations had been performed in 47 patients (50%). The baseline characteristics and the risk profile of the study population are listed in Table 1 .
Early outcomes
Postoperative outcomes are summarized in Table 2 . The overall in-hospital mortality rate was 11.7% (11 patients). The cause of death was stroke in 4 patients, severe bleeding in 2, sepsis in 2, multiorgan failure in 2 and ischaemic perforation of the oesophagus in 1 patient. Regarding neurological complications, 4 patients presented postoperative spinal cord ischaemia (SCI) (4.2%), from which 1 patient recovered after CSF drainage. A total of 23 patients experienced acute renal failure (24.4%), including 6 patients (6.3%) who required temporary dialysis and 1 patient (1%) who needed permanent dialysis. Nine patients (9.6%) had a Table 3 . The analysis revealed a significant association between a landing level at T10 or below and the occurrence of SCI (P = 0.041). The occurrence of stroke was significantly higher in diabetic patients (P = 0.024) and in patients with a history of transient ischaemic attack (P = 0.018) but not in patients requiring prolonged (>90 min) cerebral perfusion time (P = 0.558).
Furthermore, a history of transient ischaemic attack, postoperative stroke and prolonged ventilation (>3 days) and the occurrence of postoperative sepsis were significantly associated with in-hospital deaths (Table 3 ).
Outcomes at 1 year
During the 12-month follow-up period, 1 late death (sudden death) occurred 7 months after the procedure. Nine patients underwent subsequent endovascular completion (10.8% of the 83 survivors), whereas 3 patients (3.6%) required a second aortic procedure during the follow-up period (1 emergency Bentall procedure for acute dissection of the aortic root, 1 open surgical thoraco-abdominal repair and 1 open thoracic aortic procedure for aortobronchial fistula). All of these 12 patients were alive at the 12-month visit.
Imaging follow-up
The reverse aortic remodelling was marked in Segment A, both at 3 months and at 1 year (8% reduction of maximal diameter from preoperative to 1-year imaging). In Segment B, the total maximal aortic diameter had also decreased but at a slower rate than in Segment A (6% reduction). In Segment C, the aortic diameter remained stable throughout the follow-up period (1% reduction) (Figs 1 and 2) . Concordantly, in the cases of chronic aortic dissection, complete FL thrombosis was achieved in 70% of patients, and partial thrombosis was achieved in 30% of cases in Segment A at 1 year (Fig. 3) .
Complete aneurysm thrombosis was observed in 83% of patients. In the overall population, 13% of patients had endoleaks during the follow-up period (type Ib or II exclusively), requiring endovascular repair in 4% of patients. There were no instances of type Ia, III or V endoleaks or endotensions.
DISCUSSION
Diseases of the aortic arch and the descending aorta remain among the challenges in cardiovascular surgical procedures. In 1982, Borst introduced the 2-staged elephant trunk technique [12] , which has greatly facilitated surgical treatment of extensive thoracic aortic disease. Yet the technique raised 2 issues: the cumulative risks of 2 major surgical procedures [2] and the considerable number of patients not returning for the second procedure [2, 13, 14] . The evolution of endovascular therapy fuelled the development of the FET technique in the mid-1990 s [1] . The coupling of a Dacron prosthesis and a covered endovascular graft allows concomitant treatment for arch and proximal descending thoracic aortic disease. Home-made grafts were used initially [1, 15, 16] . First described in 2005 [3] , the E-Vita Open V R was the first off-the-shelf aortic hybrid prosthesis commercialized in Europe and the USA [17, 18] .
Our study focuses on the short-and mid-term outcomes of its upgraded version, the E-Vita Open Plus V R hybrid prosthesis, in elective aortic surgery for extensive chronic disease, in the context of a French national prospective multicentre registry.
Our results are consistent with other findings in literature: Pacini et al. and Tsagakis et al. reported operative mortality rates of 12% [6] and 14% [5] , respectively, for the FET technique in patients with CAD, whereas we previously reported no [10] deaths in a similar setting in a single-centre experience. Using only the E-Vita Open V R and the E-Vita Open Plus V R devices, Di Eusanio et al. observed a 15.2% mortality rate in a series including chronic aortic conditions in more than 90% of cases [19] . In his metaanalysis, Tian et al. evidenced a 8.3% pooled operative mortality rate, ranging between 0% and 18.2%, in 17 centres using different types of hybrid prostheses, in both chronic and acute aortic diseases [20] . The international E-Vita Open registry reported a 15.9% mortality rate in 509 consecutive patients [17] .
Although the FET technique has facilitated complex arch operations, SCI still represents a dreadful complication. In the largest series of the conventional elephant trunk technique, its prevalence ranged from 0% to 2.8% [21, 22] , whereas in the early reports of FET procedures, SCI was observed in up to 24% of patients [23] . Our series reports a 4.2% rate of SCI, consistent with the results from other recent studies [6, 24, 25] . Such findings may derive from a better understanding of SCI risk factors during recent years [25] . As our results suggest, and in accordance with the previous literature, a landing zone below T10 is associated with SCI [23, 25] . Nonetheless, there is controversy about the effectiveness and timing of CSF drainage. At our institution, CSF drainage is solely used postoperatively in case of symptoms related to SCI [10] .
The focus on neurological outcomes also includes the occurrence of stroke. In a conventional aortic arch operative procedure, stroke prevalence ranges between 1.1% and 9.8%, similar to that in the latest FET series [7, 24, 26] . In our series, 9.6% of patients had a stroke postoperatively. We observed an association between a history of neurological events or diabetes and postoperative stroke. Conversely, prolonged cerebral perfusion times were not associated with a higher incidence of stroke, which confirms the efficiency of selective antegrade cerebral perfusion in the management of such complex cases. Concordantly with Shrestha et al. [26] , our results indicate that postoperative stroke is significantly associated with in-hospital death.
In the setting of CAD, the capability of the FET technique to induce complete FL thrombosis remains to be evaluated [27, 28] . The progressive thickening of the intimal flap, and the presence of multiple re-entry sites distal to the stent itself, may limit FL thrombosis. In early reports, the rate of complete FL thrombosis was significantly higher in patients with acute than in those with CAD; similar findings have been observed for positive aortic remodelling [27, 28] . Nevertheless, more recent studies have reported an increasing rate of complete FL thrombosis in patients with CAD [6, 7] . In fact, Shrestha et al. [7] reported a 100% FL thrombosis rate in Segment A within 2 years of follow-up, in both chronic and acute aortic dissections. The thrombosis was, however, accelerated in acute aortic syndromes compared with CAD. Our results seem to confirm these findings in patients undergoing FET for chronic aortic pathologies. We demonstrated an increasing rate of FL thrombosis with time, from 55% at 3 months postoperatively to 70% at the 1-year follow-up. Complete FL thrombosis is predominant in Segment A (70% at 1 year) and less marked in Segments B and C (45% and 27%, respectively).
FET not only favours FL thrombosis and true lumen expansion but also induces positive aortic remodelling [7] . In fact, we have observed on average an 8% reduction of the maximal diameter in Segment A from the preoperative to the last follow-up examination; reduction was 6% in Segment B, and the maximal diameter remained stable in Segment C. These findings match the observed differential rate of FL thrombosis among the 3 aortic levels. A decrease in the risk of aortic events is thus expected [29] . Similarly, 83% of our population with degenerative aneurysms presented a complete persistent thrombosis at the 1-year follow-up.
Such findings suggest that the FET technique provides an efficient approach for treating chronic complex aortic disease, with acceptable mortality and morbidity rates. More importantly, these results appear steady over time, with a 1% mortality rate during the first year after discharge. Nonetheless, pathological evolution in the downstream aorta remains significant, as seen in 9 patients (10.8%) in our series who underwent endovascular completion and 3 patients (3.6%) who required a second aortic procedure. On the other hand, the propensity of the FET technique to lead to later endovascular completion and limited cumulated morbidity suggests that this strategy not only reduces the risk of delayed downstream aortic events but also may increase the number of patients returning for later completion.
The FET technique is also versatile: we previously reported [30] the feasibility of resecting the distal portion of the E-vita Open Plus stent graft and end-to-end anastomosis with a Dacron polyester graft in case of open distal reintervention.
Heavily calcified aneurysms or false aneurysms may represent a relative contraindication to the FET technique due to the risk of later erosion into surrounding structures such as the lung and bronchi. In our series, 1 patient presenting with this condition developed a fistula between the bronchial tree and the excluded aneurysm, leading to FET infection and reoperation.
Limitations
Our registry included only a 1-year follow-up, precluding further clinical, imaging and survival analysis. Imaging data are missing for some patients. The relatively limited study population, as well as the small number of adverse events including death, SCI and stroke, may have also limited the statistical analysis. Finally, the considerable number of participating centres introduces some heterogeneity in surgical and perioperative management (Table 4) .
CONCLUSIONS
This study is based on data from a multicentre national prospective registry. Beyond the pooling of data, it represents a multiinstitutional collaboration among 17 French centres that includes tutoring, case discussion and expertise sharing to enhance the development of a national FET aortic surgical programme.
Despite the foregoing limitations, this study demonstrates that the FET technique using the E-Vita Open Plus V R hybrid prosthesis offers an efficient treatment for chronic complex aortic diseases, with an acceptable mortality rate and a confined morbidity rate. Follow-up data indicate a good 1-year survival rate, limited reoperations in the treated segments, favourable aortic remodelling in both chronic dissection and degenerative aneurysms and possibly an increased rate of patients returning for later completion. We also underline the reproducibility of the FET technique, provided that multi-institutional collaboration and technical standardization are applied. 
